Who
Darrin Beaupre
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, IDEAYA Biosciences; VP, Clin. Med. & Early Dev., Pharmacyclics.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 9 Jul 2013
- Last trade
- 30 Jan 2026
- Last filed
- 2 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jan 2026filed 2 Feb 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 30 Jan 2026filed 2 Feb 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 27 Feb 2025filed 28 Feb 2025 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —185,000 at $0.00 | filing |
| 1 Mar 2024filed 4 Mar 2024 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 24 Feb 2023filed 28 Feb 2023 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 31 Oct 2013filed 6 Nov 2013 | Pharmacyclics | SEC FORM 4 Code J | $8,202157 at $52.24 | filing |
| 9 Jul 2013filed 11 Jul 2013 | Pharmacyclicsoption or derivative | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.